908 Devices Inc. (MASS)

Market Cap	73.01M
Revenue (ttm)	55.16M
Net Income (ttm)	-60.19M
Shares Out	34.82M
EPS (ttm)	-1.80
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	90,632
Open	2.250
Previous Close	2.030
Day's Range	2.070 - 2.250
52-Week Range	1.810 - 11.160
Beta	0.92
Analysts	Buy
Price Target	8.00 (+281.59%)
Earnings Date	Nov 12, 2024

About MASS

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracel...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Dec 18, 2020
• Employees: 230
• Stock Exchange: NASDAQ
• Ticker Symbol: MASS
• Website: https://908devices.com

Financial Performance

In 2023, 908 Devices's revenue was $50.23 million, an increase of 7.21% compared to the previous year's $46.85 million. Losses were -$36.40 million, 8.45% more than in 2022.

Analyst Forecast

According to 3 analysts, the average rating for MASS stock is "Buy." The 12-month stock price forecast is $8.0, which is an increase of 281.59% from the latest price.

Price Target

$8.0

(281.59% upside)

Analyst Consensus: Buy